Comparing Semaglutide and ESG for obesity in Brooklyn, New York, area patients

Dr. Alexander Shapsis and his team at Atlantic Gastroenterology of Brooklyn, New York, continue to stay abreast of the changes happening in the field of medically-guided weight loss. This includes recently introduced injectables designed to improve one’s weight in a safe, effective, and affordable manner. Many injectable treatments have popped up in the market today, including injectables such as Semaglutide—which is also used for the treatment of diabetes. This injectable is designed to reduce appetite and maintain satiety over time to reduce caloric intake when compared with a healthy diet and regular activity. However, there are other solutions, including endoscopic sleeve gastroplasty or ESG, which has also been used in obese patients. So which one is best? Below are four important facts to consider, including the cost-effectiveness of Semaglutide versus ESG.

Comparing Semaglutide and ESG for the treatment of obesity

• When Semaglutide and ESG are compared for cost-effectiveness, it has been found that the initial investment for endoscopic sleeve gastroplasty is a smart solution when compared to regular Semaglutide injections at Atlantic Gastroenterology in terms of long-term results.
• Over the course of five years, the ESG procedure was found to be more cost-effective than semaglutide, ensuring that patients make a smart investment overall in achieving significant weight loss for their health and wellness.
• Both options can help patients lose weight, which in turn can put them at far less risk for potential health issues, including diabetes, heart disease, and the economic costs that come with managing these conditions over a lifetime.
• Patients who are looking to invest in their health and have been researching Semaglutide injections versus ESG procedures often find that with time, the endoscopic sleeve gastroplasty is the best solution when considering the cost over several years. 

Are there limitations with Semaglutide?

While a simple injection of Semaglutide on a monthly basis with Dr. Alexander Shapsis is more of a draw than a surgical procedure, there are limitations to these injections that affect overall cost as well. Semaglutide only works with continued injections. Once patients stop their injections, they may find themselves back on track for weight gain if they haven’t made any permanent lifestyle changes and alterations to maintain their new body. However, ESG allows for long-term weight loss and continued results and often works best when paired with increased activity and improved nutrition and diet.

Schedule time to speak to Dr. Alexander Shapsis about your unique medical needs and learn more about Semaglutide, ESG, and other solutions for the treatment of obesity

Call 718 521-2840 to connect with the team at Atlantic Gastroenterology and schedule an appointment at one of either office locations in the Brooklyn, New York, area, including the Ocean Parkway location and the Court Street clinic. Dr. Alexander Shapsis is a board-certified gastroenterologist who can assist with this and several other solutions for medically-guided weight loss.

Share this Article